TY - JOUR KW - Adolescent KW - Adult KW - African Continental Ancestry Group KW - Aged KW - Case-Control Studies KW - Female KW - Gene Frequency KW - Genetic Predisposition to Disease KW - Ghana KW - Heterozygote KW - Humans KW - leprosy KW - Malaria, Falciparum KW - Male KW - Membrane Glycoproteins KW - Middle Aged KW - Polymorphism, Single Nucleotide KW - Pregnancy KW - Receptors, Interleukin-1 KW - Sepsis KW - Young Adult AU - Hamann L AU - Kumpf O AU - Schuring RP AU - Alpsoy E AU - Bedu-Addo G AU - Bienzle U AU - Oskam L AU - Mockenhaupt F AU - Schumann RR AB -
BACKGROUND: The Toll-like receptors (TLRs) mediate innate immunity to various pathogens. A mutation (S180L) in the TLR downstream signal transducer TIRAP has recently been reported to be common in Europeans and Africans and to roughly half the risks of heterogeneous infectious diseases including malaria, tuberculosis, bacteremia, and invasive pneumococal disease in heterozygous mutation carriers.
METHODS: We assessed the TIRAP S180L variant by melting curve and RFLP analysis in 1095 delivering women from malaria-endemic Ghana, as well as in a further 1114 individuals participating in case control studies on sepsis and leprosy in Germany, Turkey and Bangladesh.
RESULTS: In Ghana, the TIRAP S180L polymorphism was virtually absent. In contrast, the mutation was observed among 26.6%, 32.9% and 12% of German, Bangladesh and Turkish controls, respectively. No significant association of the heterozygous genotype with sepsis or leprosy was observed. Remarkably, homozygous TIRAP 180L tend to increase the risk of sepsis in the German study (P = 0.04).
CONCLUSION: A broad protective effect of TIRAP S180L against infectious diseases per se is not discernible.
BT - BMC medical genetics C1 - http://www.ncbi.nlm.nih.gov/pubmed/19602285?dopt=Abstract DA - 2009 Jul 14 DO - 10.1186/1471-2350-10-65 J2 - BMC Med. Genet. LA - eng N2 -BACKGROUND: The Toll-like receptors (TLRs) mediate innate immunity to various pathogens. A mutation (S180L) in the TLR downstream signal transducer TIRAP has recently been reported to be common in Europeans and Africans and to roughly half the risks of heterogeneous infectious diseases including malaria, tuberculosis, bacteremia, and invasive pneumococal disease in heterozygous mutation carriers.
METHODS: We assessed the TIRAP S180L variant by melting curve and RFLP analysis in 1095 delivering women from malaria-endemic Ghana, as well as in a further 1114 individuals participating in case control studies on sepsis and leprosy in Germany, Turkey and Bangladesh.
RESULTS: In Ghana, the TIRAP S180L polymorphism was virtually absent. In contrast, the mutation was observed among 26.6%, 32.9% and 12% of German, Bangladesh and Turkish controls, respectively. No significant association of the heterozygous genotype with sepsis or leprosy was observed. Remarkably, homozygous TIRAP 180L tend to increase the risk of sepsis in the German study (P = 0.04).
CONCLUSION: A broad protective effect of TIRAP S180L against infectious diseases per se is not discernible.
PY - 2009 EP - 65 T2 - BMC medical genetics TI - Low frequency of the TIRAP S180L polymorphism in Africa, and its potential role in malaria, sepsis, and leprosy. VL - 10 SN - 1471-2350 ER -